Navigation Links
Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results
Date:10/10/2007

48 21 471 301

EBIT- Total (349) (207) 1,376 1,095

Interest Expense - Net 10 16 17 79

Income Tax Provision

(Benefit)(A) (149) (79) 366 327

Net Income (Loss) $(210) $(144) $993 $689

(A) Includes the income tax provision (benefit) from continuing

operations, the income tax benefit on minority interest, the income

tax provision (benefit) on discontinued operations, and the income

tax benefit on the cumulative effect of a change in accounting

principle.

Reconciliation of EPS to Ongoing EPS: Ongoing EPS is calculated excluding certain after-tax items which Monsanto does not consider part of ongoing operations. The reconciliation of EPS to ongoing EPS for the fourth quarter and twelve months ended Aug. 31, 2007 and 2006, is included on page 1 of this release.

Reconciliation of Free Cash Flow: Free cash flow represents the total of cash flows from operating activities and investing activities, as reflected in the Statements of Consolidated Cash Flows presented in this release. With respect to the fiscal year 2008 free cash flow target, Monsanto does not include any estimates or projections of Net Cash Provided (Required) by Financing Activities because in order to prepare any such estimate or projection, Monsanto would need to rely on market factors and conditions that are outside of its control.

Fiscal Year 12 Months

2008 Ended

Guidance Aug. 31,

2007 2006

Net Cash Provided by Operating Activities $1,750-$1,850 $1,854 $1,674


'/>"/>

SOURCE Monsanto
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Privacy, trust still the biggest barriers to electronic record sharing
2. Visions: Wade offers straight talk on e-medical records
3. Portal to e-records boosts care at Childrens Hospital
4. Yasnoff: Wisconsin should invest in health record bank
5. Doyle seeks $30M for e-medical record adoption
6. Impact of e-medical records will be felt at home
7. Epic responds to critics of electronic record installation
8. GE Healthcare launches hybrid electronic record
9. Careful with that electronic health record, Mr. Leavitt
10. Wisconsin companies reach deal on electronic health records
11. Tommy Thompson says capital needed for electronic health records

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ario,Nov.24/PRNewswire-FirstCall/--DowAgroSciences...Seeds,adivisionofThompsonsLimitedofBlenheim,Ontari...Sciences,currentseedsbusinessasthecompanyanticipat...AgroSciencesHerbicideTolerantTraitTechnologyincorn...ure. ,, "Thisacquisitionbringstogethertwostrong...
(Date:11/24/2009)...wire-FirstCall/--Sigma-AldrichCorporation(Nasdaq: ...esday,December1stat1:45PMGMTinLondon,7:45AMUS/CST....rtheInternetavailableat http://inve s tor.sig ...ontoaccessthisfile. ,, AboutSigma-Aldrich: S...company.Itschemicalandbiochemicalproductsandkitsar...
(Date:11/24/2009)...mber24/PRNewswire-FirstCall/--deCODE,genetics,Inc....,"firstday"motionsbytheU.S.BankruptcyCourtfortheDi...weekfiledavoluntarypetitionfor,reliefunderChapter1...Court. , TheordersissuedbytheBankruptcyCourta...gtheChapter11proceedings.Inparticular,the,companyr...
(Date:11/24/2009).../PRNewswire-FirstCall/--NeurogesX,Inc.(Nasdaq: NGS...dcommercializingnovelpainmanagementtherapies,annou...tiveOfficer,isscheduledtopresentatthe21stAnnualPip...2009atTheNewYorkPalaceHotelinNewYork,NewYork. ,...cer,willbeavailabletorespondtoquestionsduringthepr...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3
...ylin Pharmaceuticals,Inc. (Nasdaq: AMLN ) will We...y, May 30, 2008 at 11:00 a.m. PT from the company,...ng the Annual Meeting, Daniel M.,Bradbury, Preside...ticals,will be providing a corporate overview., T...ding will be made,available following the event. T...
...wswire/ - ImmunoVaccine Technologies Inc. (IVT), a...mila Philip for being,recognized as one of Pennsyl...ip, Co-Founder and President of Immunotope Inc., r...rd G. Rendell., "Ramila is a champion in the biot...ry for ovarian and breast cancer is inspiring," co...
...wswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:,...it has been granted,Canadian Patent 2,360,833 enti...ferative Disorders." The claims describe the use o...mediated proliferative disorders., "This patent p...ion for,the use of reovirus compositions for cance...
Other Biology Technology:ImmunoVaccine Technologies Congratulates Dr. Ramila Philip as One of PA's Best 50 Women in Business 2Oncolytics Biotech Inc. Announces Issuance of 9th Canadian Patent 2
(Date:11/23/2009)...AMES, Iowa - The only swine vaccine available for ...herd infected with the virus. The vaccination mark...herd diagnosed with the pandemic flu., Iowa Stat...ience, developed the vaccine this summer and has b...n Iowa, Kansas and Illinois for several weeks., ...
(Date:11/23/2009)...DISON, WI, November 16, 2009 -- A USDOE and USDA s...and, idle cropland, and cropland pasture could be ...erennial grasses, such as switchgrass, from which ...edstock. Economically viable production of a peren...tities of biomass are removed annually is expected...
(Date:11/23/2009)...DURHAM, N.H. University of New Hampshire microbio... $498,115 to advance understanding of the actinorh...l to enrich nutrient-poor and contaminated soils. ...USDA) awarded Tisa, a professor of molecular, cell...the symbiotic relationship between the bacteria Fr...
Breaking Biology News(10 mins):Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Switchgrass produces biomass efficiently 2UNH prof. receives nearly $500,000 to research environmentally significant plants 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnersh 14747 1Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnersh 14747 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnersh 14747 3Top 10 Ways to Prevent or Delay Alzheimer 26apos 3Bs 60811 1Top 10 Ways to Prevent or Delay Alzheimer 26apos 3Bs 60811 2Federal Judge Rejects Tobacco Companies Effort to Block Key Provisions of New Tobacco Regulation Law 60808 1Federal Judge Rejects Tobacco Companies Effort to Block Key Provisions of New Tobacco Regulation Law 60808 2
...ool of Tropical Medicine (LSTM) and the University...ject grant to begin the development of new drugs t...llcome Trust, aims to develop new antimalarial dru...e in the respiratory chain of Plasmodium falcipar...me within the parasite is not found in humans, the...
...e University of Vermont Cardiovascular Research In...ased expression in the heart of plasminogen activa...results, which appear in the March 2009 issue of ...1 overexpression, known to accompany insulin resis...g to the high incidence of heart failure after myo...
...3 Military, homeland security, law enforcement an...nited States are being encouraged to attend the 20...VII) in northern Virginia this May 19-21. , , Nea...nty Regional Airport, just south of Marine Corps B...ives survivability demonstrations will be at range...
Other Biology News:LSTM and UoL secure £1.4m ($2m) to develop new 'magic bullet' antimalarial drug 2Plasminogen activator inhibitor type-1 -- a potential link between heart failure and diabetes 2Demonstration Targets Terrorism 2
Capped Xef-1 RNA 0.05 ml from Ambion
Human TIMP-1 ELISpot Kit from R&D Systems
Chicken Anti-Ras-related C3 botulinum toxin substrate 1 Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Anti-Human sVCAM-1 / CD106 ELI-PAIR Kit Antibody, Unconjugated from Cell Sciences
Biology Products: